1190 The Effect of Pre-Operative Hormone Replacement Therapy (HRT) on Venous Thromboembolism Risk: A Systematic Review
British Journal of Surgery · 10.07.2026 · 113 (Supplement_6)
DOI: 10.1093/bjs/znag063.612 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift British Journal of Surgery, online erschienen am 10.07.2026. Verfasst von O Helmy und 2 weiteren Autor:innen.
Themen: Thromboseprophylaxe
Abstract (Originalsprache)
Aim
Hormone replacement therapy (HRT) is widely used to manage menopausal symptoms, but its use in the perioperative period raises concerns about an increased risk of venous thromboembolism (VTE). Current clinical guidelines vary in their recommendations, with some advising temporary discontinuation of HRT prior to surgery. This systematic review aims to assess whether perioperative cessation of HRT reduces the risk of postoperative VTE.
Method
A systematic search of PubMed and the Cochrane Library was conducted to identify studies evaluating the impact of pre-operative HRT on VTE outcomes. Articles were included if they involved adult women on HRT undergoing surgery and evaluated the effects of HRT discontinuation on VTE risk. Data were extracted and synthesised narratively.
Results
The search identified 246 records, of which four met the inclusion criteria: three primary studies and one systematic review. Only one primary study directly compared perioperative continuation versus cessation of HRT and found no significant increase in postoperative VTE risk with continued use. The other studies assessed HRT as one of multiple VTE risk-factors, with inconsistent findings. A review of clinical guidelines showed consistent recognition of HRT as a potential VTE risk-factor, however few offered explicit recommendations on discontinuation.
Conclusions
Current evidence does not support routine cessation of all forms of HRT in the perioperative period, particularly in patients using transdermal preparations or receiving appropriate thromboprophylaxis. However, due to limited and inconsistent data, further research is needed to determine whether temporary withdrawal of oral estrogen formulations can meaningfully reduce postoperative VTE risk.
Zitieren
APA
Helmy, O., Sarathi, C. I. P., & Sarma, D. (2026). 1190 The Effect of Pre-Operative Hormone Replacement Therapy (HRT) on Venous Thromboembolism Risk: A Systematic Review. British Journal of Surgery, 113(Supplement_6). https://doi.org/10.1093/bjs/znag063.612
Vancouver
Helmy O, Sarathi CIP, Sarma D. 1190 The Effect of Pre-Operative Hormone Replacement Therapy (HRT) on Venous Thromboembolism Risk: A Systematic Review. British Journal of Surgery. 2026;113(Supplement_6). doi:10.1093/bjs/znag063.612
BibTeX
@article{Helmy2026,
author = {Helmy, O and Sarathi, C I Partha and Sarma, D},
title = {1190 The Effect of Pre-Operative Hormone Replacement Therapy (HRT) on Venous Thromboembolism Risk: A Systematic Review},
journal = {British Journal of Surgery},
year = {2026},
volume = {113},
number = {Supplement_6},
doi = {10.1093/bjs/znag063.612}
}
EUVIMED